THOUSAND OAKS, Calif., May 17, 2025--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to ...

Lasky, a Navy SEAL, is the second commander in the history of JTF-Micronesia. Prior to Guam, he served as deputy director of the Joint Interagency Task Force South at Naval Air Station in Key West ...

Atara Biotherapeutics' cell therapy Ebvallo should be approved to treat Epstein-Barr virus-positive post-transplant lymphoproliferative disease (EBV+ PTLD), according to the EMA's human medicines ...

Review the current Atara Biotherapeutics Inc (ATRA:XNAS) dividend yield and history to decide if ATRA is the best investment for you.

Atara Biotherapeutics Appoints James Huang and Nachi Subramanian to Board of Directors THOUSAND OAKS, Calif., May 17, 2025--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy ...

Lasky most recently served as the deputy director of the Joint Interagency Task Force South at Naval Air Station in Key West, Florida. From DeVore to Mietus ...

Get the annual and quarterly balance sheet of Atara Biotherapeutics, Inc. (ATRA) including details of assets, liabilities and shareholders' equity.

Review quarterly and annual revenue, net income, and cash flow for Atara Biotherapeutics Inc (ATRA:XNAS) stock through the last fiscal year.

Nguyen AnhCo, CEO of Atara Biotherapeutics, sells $23,307 in stock Nguyen AnhCo, the President and CEO of Atara Biotherapeutics, Inc. (NASDAQ:ATRA), recently sold shares of the company. According ...

Hydroxychloroquine is tied to reduced preeclampsia risk but not preterm birth risk in pregnant patients with lupus in a Swedish cohort study.

Protara gears up for next steps with commercial pro. Instil installs Big Pharma vet as CMO. Orca hauls in Carvykti commercial leader.